iCAD, Inc. (NASDAQ: ICAD), an industry-leading provider of Computer-Aided Detection (CAD) solutions, enables healthcare professionals to identify pathologies and pinpointing cancer earlier. The company provides a broad range of high-performance, upgradeable CAD systems and workflow solutions for mammography, Magnetic Resonance Imaging (MRI), and Computed Tomography (CT). iCAD’s solutions are available in more than 2,200 healthcare centers worldwide. For further information, visit the Company’s web site at www.icadmed.com.
- 18 years ago
QualityStocks
iCAD, Inc. (NASDAQ: ICAD)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Aims to Close Critical Gap in Early Cardiac Detection
HeartBeam (NASDAQ: BEAT) is developing technology aimed at improving how cardiac conditions are identified and monitored,…
-
QualityStocksNewsBreaks – LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) Advancing Multi-Pronged Growth Strategy Across Beacon Mill and Swanson Gold Project
Disseminated on behalf of LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) and may include paid advertising. LaFleur…
-
QualityStocksNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) and Department of Commerce Sign Letter of Intent for $100 Million in CHIPS and Science Act Funding to Accelerate U.S. Leadership in Quantum Computing
D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), the only dual-platform quantum computing company providing both annealing…